• Congratulations to Quitterie for the prize “Grandes Avancées Françaises en Biologie” from the Académie des Sciences!
    Comments Off on Congratulations to Quitterie for the prize “Grandes Avancées Françaises en Biologie” from the Académie des Sciences!

    On Tuesday, June 25, 2019, the Academy of Sciences invited young researchers / first authors, having contributed to major French scientific advances in biology, to present their results at the Institut de France. The Laureates were awarded with a medal and a prize of 2500 € (from the Mergier Bourdeix Foundation).

    Read more
  • The #COSY project received 10 million euros!
    The #COSY project received 10 million euros!
    Comments Off on The #COSY project received 10 million euros!

    The #COSY project (Cure Overgrowth SYndromes) will support fundamental research, drugs repositioning, creation of an OS department at Necker, development of new imaging modalities, state of the art genetic testing, 1st registry, promote socialization, education and communication. Congrats to the whole team!

    Read more
  • Guillaume Canaud receives the Jean Hamburger 2018 Grand Prix de Médecine!
    Guillaume Canaud receives the Jean Hamburger 2018 Grand Prix de Médecine!
    Comments Off on Guillaume Canaud receives the Jean Hamburger 2018 Grand Prix de Médecine!

    Guillaume Canaud receives the Jean Hamburger 2018 Grand Prix of Medicine from the City of Paris for the quality of his research and the major breakthrough on Cloves Syndrome. This prize, created in 1993, distinguishes a researcher aged under 45 who has made a discovery or a major scientific breakthrough.  “This is not an individual…

    Read more
  • The CLOVES Syndrome Community supports the Canaud Lab once again!
    The CLOVES Syndrome Community supports the Canaud Lab once again!
    Comments Off on The CLOVES Syndrome Community supports the Canaud Lab once again!

    On February 27, 2019, the Canaud Lab received $20,000 from the CLOVES Syndrome Community for the creation of animal models to test PIK3CA inhibitors and to study PIK3CA related overgrowth physiopathology. We are thankful and ready to take action. Learn more about the CLOVES Syndrome Community

    Read more
  • The Canaud Lab received the Jean-Pierre Lecocq Prize!
    The Canaud Lab received the Jean-Pierre Lecocq Prize!
    Comments Off on The Canaud Lab received the Jean-Pierre Lecocq Prize!

    On October 16 2018, the Canaud Lab was awarded with the Jean-Pierre Lecocq Prize from the French Academy of Sciences. Each year since 1992, this prize allocates 30 000 € for outstanding research projects in Applied and Fundamental sciences. Learn more about the French Academy of Science

    Read more
  • Grant from the Simone and Cino Del Duca Foundation
    Grant from the Simone and Cino Del Duca Foundation
    Comments Off on Grant from the Simone and Cino Del Duca Foundation

    In 2018, Guillaume Canaud received a grant from the Simone and Cino Del Duca Foundation. Three annual grants are intended for young French teams leading research projects in annually defined fields (chemistry, cellular and molecular biology, genomics, integrative biology, human biology and medical sciences and their applications). Learn more

    Read more
  • Guillaume Canaud wins the 2017 “Institut Necker” prize from the Tourre Fondation
    Guillaume Canaud wins the 2017 “Institut Necker” prize from the Tourre Fondation
    Comments Off on Guillaume Canaud wins the 2017 “Institut Necker” prize from the Tourre Fondation

    On March 5, 2018, Guillaume Canaud received the Institut Necker Prize during the annual ceremony of the Tourre Foundation, held at the Paris Descartes University, in the presence of a large audience. Since 2011, the Tourre Foundation has allocated a total of € 395,000 to support fundamental research against cancer. Learn more

    Read more
  • Congratulation to Quitterie and all the team members!
    Congratulation to Quitterie and all the team members!
    Comments Off on Congratulation to Quitterie and all the team members!

    Congratulation to Quitterie for her work on PIK3CA inhibition in patients with PIKC3CA Related Overgrowth Syndrome published in Nature! The team recently demonstrated the efficacy of a novel medication, a specific inhibitor called BYL719, in a cohort of 19 patients treated at the Necker-Enfants Malades Hospital – AP-HP and suffering from CLOVES Syndrome (Congenital Lipomatous…

    Read more

Back to Top